The CDR Life Sciences team supported Acacia Pharma on its successful €190 million Initial Global Offering (IGO) and listing on Euronext Brussels in March 2018. In raising EUR 40 million, Acacia Pharma’s listing is the largest on Euronext since 2015 and the first Pharma company listing on Euronext Brussels in 2018.
- Filter by:
- Financial and capital market communications
- Corporate communications
- Special issues, crisis and litigation
- Digital and social
- Monitoring and analysis